
To guarantee the highest purity and efficacy, we adhere to strict global standards
Erythromycin is a foundational and pioneering antibiotic belonging to the Macrolide Antibiotics class. It exhibits a broad spectrum of activity against Gram-positive bacteria and certain Gram-negative organisms. Erythromycin is a vital therapeutic agent for various respiratory and dermal infections, and serves as a key alternative for patients with penicillin allergies. We supply Erythromycin (in its Base or various salt/ester forms) with high quality and purity to support the production of tablets, suspensions, and topical formulations.
Enteric-coated tablets (to overcome acid degradation) and capsules.
The Base or its salts require acid resistance to ensure efficacy, necessitating advanced enteric coating technology during formulation.
Oral suspensions for pediatric use (often using Estolates or Ethylsuccinate esters).
The less soluble ester forms are used to create stable suspensions with improved palatability (taste masking).
Topical gel or solution for acne treatment.
Availability of high-purity grades meeting the solubility requirements for alcohol-based and other topical solvent systems.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).